Feed VS
VS

Versus Systems Inc.

VS · NASDAQ

$1.08 -0.92% (-$0.01)
1M -16.92%
Market Cap $5.29M
P/E Ratio -
Div. Yield -
ROE 16.32%
Piotroski F-Score Weak
2/9
Valuation
100 /100
Cheap
P/S 3.50x
P/B 0.45x
P/E N/A
Growth
68 /100
Growing
Rev. growth 25.28%
Book val. growth 12.24%
EPS growth N/A
Profitability
20 /100
Weak
Gross margin 100.00%
FCF margin 56.04%
Net margin 127.10%
Quality
5 /100
Poor
ROIC 69.01%
Asset turnover 0.35x
ROE 16.32%
Debt
100 /100
Low
Debt/Equity 0.00x
Current ratio 4.00x
Int. coverage N/A
Stability
48 /100
Moderate
Beta 1.37x
Profitable years 0
Rev. volatility 2,188.81%

Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more

Ask StockBot about VS
Online

About the company

Versus Systems Inc. (VS) is a technology company specializing in interactive marketing and rewards platforms. The company offers digital marketing solutions that allow brands and partners to engage their customers and audiences through contests, games, and reward systems. Versus Systems develops innovative technologies that connect content creators, brands, and consumers, creating new opportunities for engagement and entertainment. The company also provides data analytics and tools for tracking the performance of marketing campaigns. Versus Systems Inc. focuses on providing unique and entertaining experiences for users while enabling brands and partners to leverage interactive marketing to increase customer engagement and loyalty. Versus Systems Inc. (VS) shares may be an attractive investment opportunity for investors interested in the digital marketing sector and seeking an investment in a company with innovative reward and interactive marketing solutions.

Sector

Technology

Industry

Software - Application

CEO

Luis Claudio Goldner

Employees

5

Headquarters

Dover

Upcoming events

17 NOV

Earnings

Upcoming earnings report

56d

We use essential cookies to run the website and optional analytics cookies to measure usage. See our Privacy Policy.